MOG-antibody-associated disease is different from MS and NMOSD and should be classified as a distinct disease entity - Commentary

Mult Scler. 2020 Mar;26(3):276-278. doi: 10.1177/1352458519895236. Epub 2019 Dec 17.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies
  • Humans
  • Myelin-Oligodendrocyte Glycoprotein
  • Neuromyelitis Optica*

Substances

  • Antibodies
  • Myelin-Oligodendrocyte Glycoprotein